Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Telehealth on the rise, page-2910

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 2910 Last

Share
Profile

Follow
AlCp

27,387 Posts.

1778

23/06/20

17:14

Post #: 45399147
Share

Originally posted by thaiinvest ↑

Fox ... If you are right I am also wondering who would benefit from "capped' share price at these levels.

Perhaps management when they request soon for their new free options and performance shares.

Perhaps the others are doing a quid pro quo and holding down the share prices .. if so I wonder who

To me if there was an acquirer waiting in the wings I would have thought they would have launched a bid when we under A$0.10 a share or if now before the Plenex, Coviu are launched and revenue comes in

I will be voting against all compensation/ new option requests for Directors and Managers until I see more actual performance from the Board and Management and a significant higher share price. Currently they always seem a day (or months /years late) and a dollar short

I am very positive about Plenex, Coviu and the Sleep Apnea App and believe revenues will be much higher after a 3-6 months staring ramp up than many think. Hhowever I am done rewarding on MOU's where deals never materialize and promises of Jam tomorrow.

I want my cake and want it now ...damn it its Tea time

GLTA Thai

Expand

Some are due to expired in a few weeks time, don't tell me they are planning to issue new options....

RAP Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 165 more messages in this thread...

First 2910 Last

Add RAP (ASX) to my watchlist